# OnCo record paper-guadagni-rgcc-ctc-colorectal-bmc-cancer-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-guadagni-rgcc-ctc-colorectal-bmc-cancer-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-guadagni-rgcc-ctc-colorectal-bmc-cancer-2022" ;
  schema:name "Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases"@en ;
  schema:description "In 36 selected people with heavily treated colorectal cancer, a circulating tumour cell workflow predicted response with 47.2% overall accuracy and 5.3% specificity. There was no randomised comparison, and the assay was only one part of a complex treatment programme."@en ;
  schema:url <https://onco.cc/key-papers/paper-guadagni-rgcc-ctc-colorectal-bmc-cancer-2022/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://pmc.ncbi.nlm.nih.gov/articles/PMC9202660/>, <https://pubmed.ncbi.nlm.nih.gov/35710393/>, <https://doi.org/10.1186/s12885-022-09770-3> ;
  onco:tag "rgcc", "retrospective", "evidence:limited" ;
  schema:sameAs <https://doi.org/10.1186/s12885-022-09770-3> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Guadagni S, Masedu F, Fiorentini G, et al." ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/ctc-capture/>, <https://onco.cc/technologies/functional-drug-testing/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:companies <https://onco.cc/companies/rgcc-international/> .